🔗 Share this article TikTok Content Creators Driving Parallel Market for Unapproved Slimming Drug A shadow economy for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, according to new investigations. Experimental Drug Gaining Popularity Online The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers. Thriving Trade on Messaging Platforms Separately, a robust market exists on messaging services, where groups with thousands of participants share “before and after” images, administration instructions and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for transactions. Understanding Retatrutide Retatrutide is an experimental injection created by US drugmaker Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Early trials indicate it could assist patients lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic. Medical Professionals Express Concerns Nevertheless, physicians and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering substances of uncertain source. Several professionals stated the popularity for retatrutide could be connected to the rising cost of approved weight loss products such as Mounjaro. Regulatory Position and Enforcement Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed drug that cannot be promoted or supplied for human use under the British medical regulations. Some influencers try to sidestep the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still violate pharmaceutical, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment. Service Reaction and Content Elimination Based on TikTok, the platform has removed problematic content and banned related hashtags and search suggestions. The company said it was committed to keeping the platform safe and allocating resources in enhancing compliance measures. Online Trading Activities Research also discovered groups with up to 9,000 participants selling the experimental drug using the platform's integrated search feature, which functions like a public directory. Typing “retatrutide” immediately brings up channels with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for preparing or injecting at home. After minutes of entering one community, a seller posted contact information, where most transactions occur. The seller sent an guidebook and promised delivery within two days. When asked whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one inquired about body mass, health issues or past usage. Product Information and Pricing Within these communities, posts show black plastic packages with postal service stickers, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.” Buyers can choose between dry substance containers, mixed at residence with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, vendors give conflicting answers ranging from a several days to “depends on your body”. Service Moderation and Safety Measures A spokesperson for Telegram stated it regularly moderated harmful material on its service including content that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”. Healthcare Professional Cautions “Individuals are injecting materials they cannot confirm. Even if the research behind this drug is valid, these digital versions may not include what they advertise,” said a pharmacy expert, the director of pharmacy at a pharmacy service. Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly risky. You cannot know what’s contained or whether the environment they were made in was clean,” she explained. Her staff has previously seen individuals harmed by self-injection from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your health,” said the doctor. “These substances could be contaminated or improperly measured.” Producer Statement A representative from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they said, noting that any item “misleadingly claiming itself as a Lilly experimental substance not yet approved … may expose users to possibly significant medical dangers”.